{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:27:57Z","timestamp":1787840877779,"version":"build-2784847793"},"reference-count":67,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Neurological complications are a problematic factor in acute bacterial meningitis; hence, its prevention is the key to ensure the success of meningitis treatment. Glycerol and dexamethasone are both applied in this regard. Oral glycerol is an appropriate alternative instead of intravenous dexamethasone because it does not have problems related to intravenous injection, the high cost, and drug complications. The main objective of this study was to compare the efficacy of adjuvant dexamethasone versus glycerol in order to improve the clinical outcome of bacterial meningitis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>We conducted a search on the available resources including PubMed, Ovid, Elsevier, Cochrane, and another search engines such as Google till 2014. All clinical trials that were performed in the field of comparing the effectiveness of the two drugs and met the inclusion criteria were gathered and after extraction the relative risk (RR) values, the pooled RR was calculated. The main outcome was neurological complications. Meta-analysis of the data was performed in Stata version 11.2 using both fixed and random effect models, weighting each study by inverse of variance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>In 5 comparative studies (1,340 patients), the rate of neurological complications of glycerol compared to that of dexamethasone was 1.02 [95% confidence interval (CI), 0.98 compared to 1.12]. The rate of neurological complications of dexamethasone compared to dexamethasone + glycerol was 1 (95% CI, 0.97 compared to 1.03), dexamethasone compared to placebo was 0.99 (95% CI, 0.97 compared to 1.03), glycerol compared to glycerol + dexamethasone was 0.98 (95% CI, 0.94 compared to 1.02), and glycerol compared to placebo was 0.97 (95% CI, 0.94 compared to 1.01). In these studies, no difference was reported between dexamethasone and glycerol in terms of reducing neurological complications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Although there were some weak evidences for the nonstatistical significant effect of glycerol in the prevention of neurologic complication after meningitis, there was no difference between glycerol and dexamethasone.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/1735-1995.179890","type":"journal-article","created":{"date-parts":[[2016,4,8]],"date-time":"2016-04-08T16:11:18Z","timestamp":1460131878000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Meta-analysis of studies comparing adjuvant dexamethasone to glycerol to improve clinical outcome of bacterial meningitis"],"prefix":"10.4103","volume":"21","author":[{"given":"Siavash","family":"Vaziri","sequence":"first","affiliation":[{"name":"Department of Infectious and Tropical Disease, School of Medicine, Kermanshah, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiezollah","family":"Mansouri","sequence":"additional","affiliation":[{"name":"Department of Infectious and Tropical Disease, School of Medicine, Kermanshah, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babak","family":"Sayad","sequence":"additional","affiliation":[{"name":"Department of Infectious and Tropical Disease, School of Medicine, Kermanshah, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyghobad","family":"Ghadiri","sequence":"additional","affiliation":[{"name":"Department of Infectious and Tropical Disease, School of Medicine, Kermanshah, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Torkashvand","sequence":"additional","affiliation":[{"name":"Department of Infectious and Tropical Disease, School of Medicine, Kermanshah, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansour","family":"Rezaei","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Epidemiology, School of Public Health, Kermanshah University of Medical Sciences, Kermanshah, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farid","family":"Najafi","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Epidemiology, School of Public Health, Kermanshah University of Medical Sciences, Kermanshah, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Azizi","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2016,4,8]]},"reference":[{"key":"R1-20250827","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1056\/NEJMra052116","article-title":"Community-acquired bacterial meningitis in adults","volume":"354","author":"van de Beek","year":"2006","journal-title":"N Engl J Med"},{"key":"R2-20250827","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/00006454-199305000-00008","article-title":"Outcomes of bacterial meningitis in children: A meta-analysis","volume":"12","author":"Baraff","year":"1993","journal-title":"Pediatr Infect Dis J"},{"key":"R3-20250827","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1542\/peds.112.5.1049","article-title":"Hearing loss at school age in survivors of bacterial meningitis: Assessment, incidence, and prediction","volume":"112","author":"Koomen","year":"2003","journal-title":"Pediatrics"},{"key":"R4-20250827","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1136\/adc.76.2.134","article-title":"Hearing loss during bacterial meningitis","volume":"76","author":"Richardson","year":"1997","journal-title":"Arch Dis Child"},{"key":"R5-20250827","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1136\/adc.83.2.111","article-title":"Twelve year outcomes following bacterial meningitis: Further evidence for persisting effects","volume":"83","author":"Grimwood","year":"2000","journal-title":"Arch Dis Child"},{"key":"R6-20250827","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s12098-007-0062-6","article-title":"Predictors of long term neurological outcome in bacterial meningitis","volume":"74","author":"Singhi","year":"2007","journal-title":"Indian J Pediatr"},{"key":"R7-20250827","first-page":"663","article-title":"A clinical study of chronic morbidity in children following pyogenic meningitis","volume":"39","author":"George","year":"2002","journal-title":"Indian Pediatr"},{"key":"R8-20250827","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/tropej\/fmh075","article-title":"Long-term outcome for children with bacterial meningitis in rural Papua New Guinea","volume":"51","author":"Wandi","year":"2005","journal-title":"J Trop Pediatr"},{"key":"R9-20250827","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1128\/CMR.13.2.302","article-title":"Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: Global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates","volume":"13","author":"Peltola","year":"2000","journal-title":"Clin Microbiol Rev"},{"key":"R10-20250827","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00006454-200003000-00003","article-title":"Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group","volume":"19","author":"Black","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"R11-20250827","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1097\/INF.0b013e318175d177","article-title":"Increase in serum osmolality is possible mechanism for the beneficial effects of glycerol in childhood bacterial meningitis","volume":"27","author":"Singhi","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"R12-20250827","first-page":"66","article-title":"Estadoactual de la yacunuconjugadacotra Streptococcus pneumonia","volume":"48","author":"Sierra-Fernandez","year":"2006","journal-title":"Acta Med Croatica"},{"key":"R13-20250827","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/S0140-6736(89)92685-8","article-title":"Randomised comparison of chloramphenicol, ampicillin, cefotaxime, and ceftriaxone for childhood bacterial meningitis. Finnish Study Group","volume":"333","author":"Peltola","year":"1989","journal-title":"Lancet"},{"key":"R14-20250827","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1056\/NEJM198810133191502","article-title":"Dexamethasone therapy for bacterial meningitis. Results of two double-blind, placebo-controlled trials","volume":"319","author":"Lebel","year":"1988","journal-title":"N Engl J Med"},{"key":"R15-20250827","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/infdis\/160.5.818","article-title":"Modulation of inflammation and cachectin activity in relation to treatment of experimental Hemophilus influenzae type b meningitis","volume":"160","author":"Mustafa","year":"1989","journal-title":"J Infect Dis"},{"key":"R16-20250827","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1056\/NEJM199105303242201","article-title":"The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis","volume":"324","author":"Odio","year":"1991","journal-title":"N Engl J Med"},{"key":"R17-20250827","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0140-6736(93)91592-A","article-title":"Dexamethasone therapy for bacterial meningitis in children. Swiss Meningitis Study Group","volume":"342","author":"Schaad","year":"1993","journal-title":"Lancet"},{"key":"R18-20250827","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0891-5520(05)70097-0","article-title":"Antimicrobial and anti-inflammatory treatment of bacterial meningitis","volume":"13","author":"S\u00e1ez-Llorens","year":"1999","journal-title":"Infect Dis Clin North Am"},{"key":"R19-20250827","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0891-5520(05)70093-3","article-title":"Pathogenesis of bacterial meningitis","volume":"13","author":"Leib","year":"1999","journal-title":"Infect Dis Clin North Am"},{"key":"R20-20250827","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s11908-000-0012-1","article-title":"New advances in the pathogenesis and pathophysiology of bacterial meningitis","volume":"2","author":"Nathan","year":"2000","journal-title":"Curr Infect Dis Rep"},{"key":"R21-20250827","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1016\/S0140-6736(03)13693-8","article-title":"Bacterial meningitis in children","volume":"361","author":"S\u00e1ez-Llorens","year":"2003","journal-title":"Lancet"},{"key":"R22-20250827","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0022-3476(05)80683-3","article-title":"Cerebral blood flow and carbon dioxide reactivity in children with bacterial meningitis","volume":"117","author":"Ashwal","year":"1990","journal-title":"J Pediatr"},{"key":"R23-20250827","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1093\/clind\/15.5.840","article-title":"Antibiotic-induced release of endotoxin: A reappraisal","volume":"15","author":"Hurley","year":"1992","journal-title":"Clin Infect Dis"},{"key":"R24-20250827","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0022-3476(05)82647-2","article-title":"Molecular pathophysiology of bacterial meningitis: Current concepts and therapeutic implications","volume":"116","author":"S\u00e1ez-Llorens","year":"1990","journal-title":"J Pediatr"},{"key":"R25-20250827","doi-asserted-by":"crossref","first-page":"610","DOI":"10.7326\/0003-4819-112-8-610","article-title":"Bacterial meningitis: Recent advances in pathophysiology and treatment","volume":"112","author":"Tunkel","year":"1990","journal-title":"Ann Intern Med"},{"key":"R26-20250827","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1056\/NEJM199209173271208","article-title":"Bacterial meningitis: Pathogenesis, pathophysiology, and progress","volume":"327","author":"Quagliarello","year":"1992","journal-title":"N Engl J Med"},{"key":"R27-20250827","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1093\/infdis\/151.3.528","article-title":"Effects of ampicillin and corticosteroids on brain water content, cerebrospinal fluid pressure, and cerebrospinal fluid lactate levels in experimental pneumococcal meningitis","volume":"151","author":"T\u00e4uber","year":"1985","journal-title":"J Infect Dis"},{"key":"R28-20250827","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1172\/JCI114292","article-title":"Tumor necrosis factor in mediating experimental Haemophilus influenzae type B meningitis","volume":"84","author":"Mustafa","year":"1989","journal-title":"J Clin Invest"},{"key":"R29-20250827","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1172\/JCI115527","article-title":"Enhanced attenuation of meningeal inflammation and brain edema by concomitant administration of anti-CD18 monoclonal antibodies and dexamethasone in experimental Haemophilus meningitis","volume":"88","author":"S\u00e1ez-Llorens","year":"1991","journal-title":"J Clin Invest"},{"key":"R30-20250827","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1086\/522534","article-title":"Adjuvant glycerol and\/or dexamethasone to improve the outcomes of childhood bacterial meningitis: A prospective, randomized, double-blind, placebo-controlled trial","volume":"45","author":"Peltola","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R31-20250827","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3171\/jns.1964.21.4.0278","article-title":"Oral glycerol for the reduction of intracranial pressure","volume":"21","author":"Cantore","year":"1964","journal-title":"J Neurosurg"},{"key":"R32-20250827","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/00006454-199504000-00005","article-title":"Oral glycerol versus intravenous dexamethasone in preventing neurologic and audiologic sequelae of childhood bacterial meningitis. The Finnish Study Group","volume":"14","author":"Kilpi","year":"1995","journal-title":"Pediatr Infect Dis J"},{"key":"R33-20250827","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1097\/00006454-198912000-00004","article-title":"Dexamethasone treatment for bacterial meningitis in children and adults","volume":"8","author":"Girgis","year":"1989","journal-title":"Pediatr Infect Dis J"},{"key":"R34-20250827","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1001\/jama.1997.03550110063038","article-title":"Dexamethasone as adjunctive therapy in bacterial meningitis. A meta-analysis of randomized clinical trials since 1988","volume":"278","author":"Mclntyre","year":"1997","journal-title":"JAMA"},{"key":"R35-20250827","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1001\/jama.1963.63700060029012","article-title":"The effectiveness of hydrocortisone in the management of severe infections","volume":"183","author":"Group","year":"1963","journal-title":"JAMA"},{"key":"R36-20250827","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1542\/peds.44.1.30","article-title":"Corticosteroids as an adjunct to treatment in bacterial meningitis. A controlled clinical trial","volume":"44","author":"DeLemos","year":"1969","journal-title":"Pediatrics"},{"key":"R37-20250827","first-page":"301","article-title":"Magnetic resonance imaging and dexamethasone therapy for bacterial meningitis","volume":"143","author":"Lebel","year":"1989","journal-title":"Am J Dis Child"},{"key":"R38-20250827","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMoa070852","article-title":"Dexamethasone in Vietnamese adolescents and adults with bacterial meningitis","volume":"357","author":"Nguyen","year":"2007","journal-title":"N Engl J Med"},{"key":"R39-20250827","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1056\/NEJMoa065711","article-title":"Corticosteroids for bacterial meningitis in adults in sub-Saharan Africa","volume":"357","author":"Scarborough","year":"2007","journal-title":"N Engl J Med"},{"key":"R40-20250827","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/j.1468-1331.2009.02615.x","article-title":"Adjunctive dexamethasone therapy for bacterial meningitis in adults: A meta-analysis of randomized controlled trials","volume":"16","author":"Vardakas","year":"2009","journal-title":"Eur J Neurol"},{"key":"R41-20250827","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0025-6196(11)60558-2","article-title":"Corticosteroid administration and outcome of adolescents and adults with acute bacterial meningitis: A meta-analysis","volume":"84","author":"Assiri","year":"2009","journal-title":"Mayo Clin Proc"},{"key":"R42-20250827","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004405.pub2","article-title":"Corticosteroids for acute bacterial meningitis","author":"van de Beek","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"R43-20250827","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/ncpneuro0265","article-title":"Drug insight: Adjunctive therapies in adults with bacterial meningitis","volume":"2","author":"van de Beek","year":"2006","journal-title":"Nat Clin Pract Neurol"},{"key":"R44-20250827","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004405.pub3","article-title":"Corticosteroids for acute bacterial meningitis","author":"Brouwer","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"R45-20250827","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1001\/archpedi.1989.02150210085023","article-title":"Corticosteroids as adjunctive therapy in bacterial meningitis: A meta-analysis of clinical trials","volume":"143","author":"Havens","year":"1989","journal-title":"Am J Dis Chil"},{"key":"R46-20250827","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S1473-3099(04)00937-5","article-title":"Steroids in adults with acute bacterial meningitis: A systematic review","volume":"4","author":"van de Beek","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"R47-20250827","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S1474-4422(10)70023-5","article-title":"Adjunctive dexamethasone in bacterial meningitis: A meta-analysis of individual patient data","volume":"9","author":"van de Beek","year":"2010","journal-title":"Lancet Neurol"},{"key":"R48-20250827","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(75)91825-5","article-title":"Controlled trial of glycerol versus dexamethasone in the treatment of cerebral edema in acute cerebral infarction","volume":"1","author":"Gilsanz","year":"1975","journal-title":"Lancet"},{"key":"R49-20250827","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0006-8993(81)90324-3","article-title":"Differential effects of hypertonic mannitol and glycerol on rat brain metabolism and amino acids","volume":"225","author":"Chan","year":"1981","journal-title":"Brain Res"},{"key":"R50-20250827","first-page":"H299","article-title":"Lower limits of cerebrovascular permeability to nonelectrolytes in the conscious rat","volume":"235","author":"Ohno","year":"1978","journal-title":"Am J Physiol"},{"key":"R51-20250827","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s10787-998-0003-7","article-title":"Glycerol does not reduce neuronal damage in experimental Streptococcus pneumoniae meningitis in rabbits","volume":"6","author":"Schmidt","year":"1998","journal-title":"Inflammopharmacology"},{"key":"R52-20250827","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1471-2334-10-84","article-title":"Adjuvant glycerol is not beneficial in experimental pneumococcal meningitis","volume":"10","author":"Blaser","year":"2010","journal-title":"BMC Infect Dis"},{"key":"R53-20250827","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1161\/01.STR.24.8.1119","article-title":"Treatment of acute cortical infarct with intravenous glycerol. A double-blind, placebo-controlled randomized trial","volume":"24","author":"Yu","year":"1993","journal-title":"Stroke"},{"key":"R54-20250827","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/S0140-6736(71)90321-7","article-title":"Treatment with glycerol of cerebral oedema due to acute cerebral infarction","volume":"2","author":"Meyer","year":"1971","journal-title":"Lancet"},{"key":"R55-20250827","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/cpt1972132159","article-title":"Cerebral dehydration action of glycerol. I. Historical aspects with emphasis on the toxicity and intravenous administration","volume":"13","author":"Tourtellotte","year":"1972","journal-title":"Clin Pharmacol Ther"},{"key":"R56-20250827","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1212\/WNL.27.7.600","article-title":"The effect of oral glycerol on intraventricular pressure in man","volume":"27","author":"Rottenberg","year":"1977","journal-title":"Neurology"},{"key":"R57-20250827","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1212\/WNL.32.4.437","article-title":"Intravenous glycerol and mannitol therapy in children with intracranial hypertension","volume":"32","author":"MacDonald","year":"1982","journal-title":"Neurology"},{"key":"R58-20250827","first-page":"359","article-title":"Clinical study of mannitol and glycerol on raised intracranial pressure and on their rebound phenomenon","volume":"52","author":"Node","year":"1989","journal-title":"Adv Neurol"},{"key":"R59-20250827","first-page":"553","article-title":"Intravenous glycerol in the treatment of intracranial hypertension.(Preliminary note)","volume":"73","author":"Cantore","year":"1966","journal-title":"Policlinico Prat"},{"key":"R60-20250827","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/S0140-6736(72)92775-4","article-title":"Double-blind evaluation of glycerol therapy in acute cerebral infarction","volume":"2","author":"Mathew","year":"1972","journal-title":"Lancet"},{"key":"R61-20250827","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0140-6736(87)90117-6","article-title":"Double-blind randomised trial of intravenous glycerol in acute stroke","volume":"329","author":"Bayer","year":"1987","journal-title":"Lancet"},{"key":"R62-20250827","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0022-510X(75)90035-0","article-title":"The effects of glycerol on cerebral ultrastructure following experimentally induced cerebral ischemia","volume":"26","author":"Dodson","year":"1975","journal-title":"J Neurol Sci"},{"key":"R63-20250827","first-page":"541","article-title":"Effect of timing and dose of the hyperosmotic agent glycerol on experimental ischemic brain edema and metabolites","volume":"52","author":"Kashiwagi","year":"1990","journal-title":"Adv Neurol"},{"key":"R64-20250827","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S1473-3099(10)70317-0","article-title":"Glycerol adjuvant therapy in adults with bacterial meningitis in a high HIV seroprevalence setting in Malawi: A double-blind, randomised controlled trial","volume":"11","author":"Ajdukiewicz","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"R65-20250827","first-page":"649","article-title":"Role of dexamethasone and oral glycerol in reducing hearing and neurological sequelae in children with bacterial meningitis","volume":"44","author":"Sankar","year":"2007","journal-title":"Indian Pediatr"},{"key":"R66-20250827","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1542\/peds.2009-0395","article-title":"Hearing impairment in childhood bacterial meningitis is little relieved by dexamethasone or glycerol","volume":"125","author":"Peltola","year":"2010","journal-title":"Pediatrics"},{"key":"R67-20250827","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s11908-012-0271-7","article-title":"Use of corticosteroids and other adjunct therapies for acute bacterial meningitis in adults","volume":"14","author":"Prasad","year":"2012","journal-title":"Curr Infect Dis Rep"}],"container-title":["Journal of Research in Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01222967-201621000-00022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:31:21Z","timestamp":1787837481000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01222967-201621000-00022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.4103\/1735-1995.179890","relation":{},"ISSN":["1735-1995","1735-7136"],"issn-type":[{"value":"1735-1995","type":"print"},{"value":"1735-7136","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"2015-09-10","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-02-09","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}